When: 22 - 24 March 2021
Where: Online
Day 1 start time: 09:00 GMT | Day 3 end time: 15:15 GMT
Course overview
This Masterclass covers:
- Different classes of biological products such as vaccines, monoclonal antibodies and gene therapy medicinal products
- Practical regulatory aspects of regulatory strategy for biological, biotechnology and advanced therapy products
- Regulatory Requirements for clinical trial applications and marketing applications
- The quality, non-clinical and clinical changes specific to biological products
- Implications of changes to the production of biological products and the concept of compatibility
- Case studies to apply the regulatory principals
The combination of lectures and case studies and workshops will assist in the achievement of the learning outcomes and enable the students to contextualise their understanding and knowledge.
Great overview of an area in the pharmaceutical industry that not many are exposed to. Biological, biotechnology and ATMP are the future so all in the pharmaceutical industry should know about this topic.” – 2018 delegate
Benefits to delegates
This course will enable you to:
- Display a systematic understanding of knowledge and a critical awareness of the unique nature and strategies for development of biological, biotechnology and advanced therapy products
- Possess a comprehensive understanding of the regulatory requirements and associated documentation with the licencing of biological, biotechnology and advanced therapy products
- Demonstrate a conceptual understanding of the legal and pharmaceutical requirements that define the regulatory strategy for biological, biotechnology and advanced therapy products
- Deal with complex issues both systematically and creatively, make sound judgements in the absence of complete data, and communicate their conclusions clearly to specialist and non specialist audiences regarding biological, biotechnology and advanced therapy products
- Demonstrate the ability to critically analyse the legal documentation and regulatory considerations of biological, biotechnology and advanced therapy products
- Critically appraise and evaluate communications from regulatory bodies and research publications regarding biological, biotechnology and advanced therapy products
CPD: This course provides 19 CPD hours upon successful completion. To learn more about why Continuing Professional Development is important, visit our Lifelong Learning page.
Programme
The programme is available HERE.
Presenters
TOPRA Masterclasses are developed and delivered by a faculty of expert speakers from relevant industry, agencies, notified bodies and other stakeholders, and are validated by the University of Hertfordshire. Speakers for this course to be announced.
Suitable for
- Students of the TOPRA MSc programme
- Delegates from the regulatory affairs industry who wish to develop their knowledge of biological, biotech and advanced therapy products
- Delegates from allied industries who wish to have a comprehensive understanding of the subject
Pricing
Standard
- Student: £1500 + VAT
- Delegate: £1700 + VAT
Discounted places
A limited number of discounted places are available at the rates below. Please note that discounted places are not valid for those enrolled on the MSc course.
Please email us at meetings@topra.org for a discount code before making your booking.
Discounted prices
- Those working for regulatory agencies, government agencies or academic institutions: £1275 + VAT
- Those working for charities, patient groups or in full-time education: £1275 + VAT
* VAT, if applicable, is charged at the rate of 20% Pricing
*VAT, if applicable, is charged at the rate of 20%.
Terms and conditions
By booking a place on this course you are agreeing to the training terms and conditions.